Loomis Sayles & CO L P Blueprint Medicines Corp Transaction History

Loomis Sayles & CO L P

$76.2 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $196,973 - $306,526	-3,945 Reduced 1.2%	325,815 $21.5 Million
Q2 2022 Aug 05, 2022	SELL	$45.23 - $70.15 $4.9 Million - $7.59 Million	-108,262 Reduced 24.72%	329,760 $16.7 Million
Q1 2022 May 13, 2022	BUY	$54.1 - $110.08 $3.19 Million - $6.49 Million	58,923 Added 15.54%	438,022 $28 Million
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $964,083 - $1.19 Million	-10,229 Reduced 2.63%	379,099 $40.6 Million
Q3 2021 Nov 12, 2021	SELL	$80.98 - $109.47 $489,119 - $661,198	-6,040 Reduced 1.53%	389,328 $40 Million
Q2 2021 Aug 13, 2021	SELL	$82.78 - $101.0 $665,054 - $811,434	-8,034 Reduced 1.99%	395,368 $34.8 Million
Q1 2021 May 17, 2021	BUY	$90.71 - $108.28 $4.36 Million - $5.2 Million	48,011 Added 13.51%	403,402 $39.2 Million
Q4 2020 Feb 12, 2021	SELL	$92.08 - $124.48 $193,091 - $261,034	-2,097 Reduced 0.59%	355,391 $39.9 Million
Q3 2020 Nov 12, 2020	BUY	$66.45 - $92.7 $3.21 Million - $4.48 Million	48,289 Added 15.62%	357,488 $33.1 Million
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $17.7 Million - $24.5 Million	309,199 New	309,199 $24.1 Million
Q1 2020 May 15, 2020	SELL	$48.11 - $82.22 $20.5 Million - $35.1 Million	-426,978 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$66.73 - $82.59 $820,912 - $1.02 Million	-12,302 Reduced 2.8%	426,978 $34.2 Million
Q3 2019 Nov 13, 2019	BUY	$72.9 - $101.41 $4.67 Million - $6.49 Million	64,012 Added 17.06%	439,280 $32.3 Million
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $331,003 - $440,197	4,501 Added 1.21%	375,268 $35.4 Million
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $651,216 - $1.16 Million	13,372 Added 3.74%	370,767 $29.7 Million
Q4 2018 Feb 14, 2019	BUY	$45.57 - $74.26 $12.4 Million - $20.3 Million	273,142 Added 324.19%	357,395 $19.3 Million
Q3 2018 Nov 13, 2018	BUY	$58.91 - $78.32 $4.96 Million - $6.6 Million	84,253 New	84,253 $6.58 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$605 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.65M
Shares

$601 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.39M
Shares

$487 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

3.96M
Shares

$359 Million
0.07% of portfolio
State Street Corp Boston, MA

2.77M
Shares

$250 Million
0.01% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account